Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Steinberg et al.
NEJM 2008;359:529-530.
FULL TEXT
Dietary Fiber and the Relationship to Chronic Diseases
Timm and Slavin
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:233-240.
ABSTRACT
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?
Barter and Rye
Arterioscler. Thromb. Vasc. Bio. 2008;28:39-46.
ABSTRACT
| FULL TEXT
State of the Art Reviews: Relationship Between Diet/ Physical Activity and Health
O'Neil and Nicklas
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:457-481.
ABSTRACT
Glucuronidation Converting Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a Potent Apical Sodium-Dependent Bile Acid Transporter Inhibitor, Resulting in a Hypocholesterolemic Action
Sakamoto et al.
J. Pharmacol. Exp. Ther. 2007;322:610-618.
ABSTRACT
| FULL TEXT
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Nogueira and Weir
CJASN 2007;2:766-785.
ABSTRACT
| FULL TEXT
Nonfasting Low-Density Lipoprotein Testing: Utility for Cholesterol Screening in Pediatric Primary Care
de Ferranti et al.
CLIN PEDIATR 2007;46:441-445.
ABSTRACT
Optimal Low-Density Lipoprotein Cholesterol Lowering-- Morning Versus Evening Statin Administration
Plakogiannis and Cohen
The Annals of Pharmacotherapy 2007;41:106-110.
ABSTRACT
| FULL TEXT
A 39-year-old woman with hypercholesterolemia.
Mittleman
JAMA 2006;296:319-326.
ABSTRACT
| FULL TEXT
THE GREAT DEBATE EDITORIAL, REVISITED: RESPONSE
Freedland et al.
Psychosom. Med. 2006;68:638-640.
FULL TEXT
Vascular Biomarkers and Surrogates in Cardiovascular Disease
Tardif et al.
Circulation 2006;113:2936-2942.
ABSTRACT
| FULL TEXT
Profiling risk: the emergence of coronary heart disease epidemiology in the United States (1947-70)
Oppenheimer
Int J Epidemiol 2006;35:720-730.
ABSTRACT
| FULL TEXT
Role of the Pharmacist in the Management of Dyslipidemia
Olson and Potts
Journal of Pharmacy Practice 2006;19:94-102.
ABSTRACT
Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it--almost
Steinberg
J. Lipid Res. 2006;47:1-14.
ABSTRACT
| FULL TEXT
Stimulation of Liver-Directed Cholesterol Flux in Mice by Novel N-Acetylgalactosamine-Terminated Glycolipids With High Affinity for the Asialoglycoprotein Receptor
Rensen et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:169-175.
ABSTRACT
| FULL TEXT
High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial
Pedersen et al.
JAMA 2005;294:2437-2445.
ABSTRACT
| FULL TEXT
The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism
Claudel et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:2020-2030.
ABSTRACT
| FULL TEXT
Anorectics on Trial: A Half Century of Federal Regulation of Prescription Appetite Suppressants
Colman
ANN INTERN MED 2005;143:380-385.
ABSTRACT
| FULL TEXT
Patient Adherence Improves Glycemic Control
Rhee et al.
The Diabetes Educator 2005;31:240-250.
ABSTRACT
| FULL TEXT
Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans
Steinberg
J. Lipid Res. 2005;46:179-190.
ABSTRACT
| FULL TEXT
Pathogenesis of Atherosclerosis
Crowther
ASH Education Book 2005;2005:436-441.
ABSTRACT
| FULL TEXT
Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia
Meagher
J Am Board Fam Med 2004;17:424-437.
ABSTRACT
| FULL TEXT
Clinical Chemistry Journal Has Contributed to Progress in Lipid and Lipoprotein Testing for Fifty Years
Rifai et al.
Clin. Chem. 2004;50:1861-1870.
FULL TEXT
CYP7A1 A-278C Polymorphism Affects the Response of Plasma Lipids after Dietary Cholesterol or Cafestol Interventions in Humans
Hofman et al.
J. Nutr. 2004;134:2200-2204.
ABSTRACT
| FULL TEXT
The Toxicology of HMG--CoA Reductase Inhibitors: Prediction of Human Risk
MacDonald and Halleck
Toxicol Pathol 2004;32:26-41.
ABSTRACT
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity
Vaudo et al.
Ann Rheum Dis 2004;63:31-35.
ABSTRACT
| FULL TEXT
Soy Protein Enhances the Cholesterol-Lowering Effect of Plant Sterol Esters in Cholesterol-Fed Hamsters
Lin et al.
J. Nutr. 2004;134:143-148.
ABSTRACT
| FULL TEXT
Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (>=12 Months) Follow-Up Intravascular Ultrasound
von Birgelen et al.
Circulation 2003;108:2757-2762.
ABSTRACT
| FULL TEXT
The Northern Sweden MONICA project: concluding remarks
Asplund and Wall
Scand J Public Health 2003;31:78-84.
DAIS: how it relates to other lipid intervention studies in diabetes
Steiner
British Journal of Diabetes & Vascular Disease 2003;3:212-215.
ABSTRACT
Medicine partnerships
Cramer
Heart 2003;89:ii19-21.
ABSTRACT
| FULL TEXT
Donald Sharp Fredrickson, MD: 1924-2002
Gotto
Circulation 2003;107:1714-1716.
FULL TEXT
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
Knopp et al.
Eur Heart J 2003;24:729-741.
ABSTRACT
| FULL TEXT
Differential Effects of Lipid-Lowering Therapies on Stroke Prevention: A Meta-analysis of Randomized Trials
Corvol et al.
Arch Intern Med 2003;163:669-676.
ABSTRACT
| FULL TEXT
Automating Complex Guidelines for Chronic Disease: Lessons Learned
Maviglia et al.
J. Am. Med. Inform. Assoc. 2003;10:154-165.
ABSTRACT
| FULL TEXT
References
Circulation 2002;106:3373-3421.
FULL TEXT
Inhibition of the Apical Sodium-Dependent Bile Acid Transporter Reduces LDL Cholesterol and ApoB by Enhanced Plasma Clearance of LDL ApoB
Huff et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1884-1891.
ABSTRACT
| FULL TEXT
Donald S. Fredrickson, MD: 1924-2002
Gotto
Arterioscler. Thromb. Vasc. Bio. 2002;22:1506-1508.
FULL TEXT
Hypertensive retinopathy and incident coronary heart disease in high risk men
Duncan et al.
Br. J. Ophthalmol. 2002;86:1002-1006.
ABSTRACT
| FULL TEXT
Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study
McKeown et al.
Am. J. Clin. Nutr. 2002;76:390-398.
ABSTRACT
| FULL TEXT
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials: Prospective Pravastatin Pooling (PPP) Project
Pfeffer et al.
Circulation 2002;105:2341-2346.
ABSTRACT
| FULL TEXT
Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity: Data From the Third National Health and Nutrition Examination Survey
Nelson et al.
Arch Intern Med 2002;162:929-935.
ABSTRACT
| FULL TEXT
A Community-Wide Survey of Physician Practices and Attitudes Toward Cholesterol Management in Patients With Recent Acute Myocardial Infarction
Yarzebski et al.
Arch Intern Med 2002;162:797-804.
ABSTRACT
| FULL TEXT
Effect of a Rapeseed Oil Substituting Diet on Serum Lipids and Lipoproteins in Children and Adolescents with Familial Hypercholesterolemia
Gulesserian and Widhalm
J. Am. Coll. Nutr. 2002;21:103-108.
ABSTRACT
| FULL TEXT
Why some patients respond poorly to statins and how this might be remedied
Thompson et al.
Eur Heart J 2002;23:200-206.
FULL TEXT
Lipoproteins, nutrition, and heart disease
Schaefer
Am. J. Clin. Nutr. 2002;75:191-212.
ABSTRACT
| FULL TEXT
Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation
Nauck et al.
Clin. Chem. 2002;48:236-254.
ABSTRACT
| FULL TEXT
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
Cheung et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:1320-1326.
ABSTRACT
| FULL TEXT
Fluvastatin inhibits O2- and ICAM-1 levels in a rat model with aortic remodeling induced by pressure overload
Katoh et al.
Am. J. Physiol. Heart Circ. Physiol. 2001;281:H655-H660.
ABSTRACT
| FULL TEXT
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet
Maki et al.
Am. J. Clin. Nutr. 2001;74:33-43.
ABSTRACT
| FULL TEXT
A Novel Test for the Measurement of Skin Cholesterol
Zawydiwski et al.
Clin. Chem. 2001;47:1302-1304.
FULL TEXT
Temporal Trends (1986-1997) in Cholesterol Level Assessment and Management Practices in Patients With Acute Myocardial Infarction: A Population-Based Perspective
Yarzebski et al.
Arch Intern Med 2001;161:1521-1528.
ABSTRACT
| FULL TEXT
Coffee Consumption and Serum Lipids: A Meta-Analysis of Randomized Controlled Clinical Trials
Jee et al.
Am J Epidemiol 2001;153:353-362.
ABSTRACT
| FULL TEXT
Effects of Estrone Sulfate Alone or With Medroxyprogesterone Acetate on Serum Lipoprotein Levels in Postmenopausal Women
LUCIANO et al.
Obstet Gynecol 2001;97:101-108.
ABSTRACT
| FULL TEXT
Dietary fat intakes in infants and primary school children in Germany
Koletzko et al.
Am. J. Clin. Nutr. 2000;72
:1392S-1398S.
ABSTRACT
| FULL TEXT
A Reference Method Laboratory Network for Cholesterol: A Model for Standardization and Improvement of Clinical Laboratory Measurements
Myers et al.
Clin. Chem. 2000;46:1762-1772.
ABSTRACT
| FULL TEXT
Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials
Pignone et al.
BMJ 2000;321:983-986.
ABSTRACT
| FULL TEXT
Analytical and Clinical Evaluation of Two Homogeneous Assays for LDL-Cholesterol in Hyperlipidemic Patients
Esteban-Salan et al.
Clin. Chem. 2000;46:1121-1131.
ABSTRACT
| FULL TEXT
Do Triglycerides Provide Meaningful Information About Heart Disease Risk?
Avins and Neuhaus
Arch Intern Med 2000;160:1937-1944.
ABSTRACT
| FULL TEXT
Multiple mechanisms, independent of sterol regulatory element binding proteins, regulate low density lipoprotein gene transcription
Makar et al.
J. Lipid Res. 2000;41:762-774.
ABSTRACT
| FULL TEXT
Consumption of Soy Protein Reduces Cholesterol Absorption Compared to Casein Protein Alone or Supplemented with an Isoflavone Extract or Conjugated Equine Estrogen in Ovariectomized Cynomolgus Monkeys
Greaves et al.
J. Nutr. 2000;130:820-826.
ABSTRACT
| FULL TEXT
Hereditary dyslipidaemias and combined risk factors in children with a family history of premature coronary artery disease
Sveger et al.
Arch. Dis. Child. 2000;82:292-296.
ABSTRACT
| FULL TEXT
Cholesterol Screening in Children and Adolescents
Newman and MD
Pediatrics 2000;105:637-638.
FULL TEXT
The Colorado Thyroid Disease Prevalence Study
Canaris et al.
Arch Intern Med 2000;160:526-534.
ABSTRACT
| FULL TEXT
The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)
Kristal-Boneh et al.
Eur Heart J 2000;21:116-124.
ABSTRACT
Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury
Indolfi et al.
J Am Coll Cardiol 2000;35:214-221.
ABSTRACT
| FULL TEXT
A Randomized Trial of Oral Contraceptive and Hormone Replacement Therapy on Bone Mineral Density and Coronary Heart Disease Risk Factors in Postmenopausal Women
TAECHAKRAICHANA et al.
Obstet Gynecol 2000;95:87-94.
ABSTRACT
| FULL TEXT
Colesevelam Hydrochloride (Cholestagel): A New, Potent Bile Acid Sequestrant Associated With a Low Incidence of Gastrointestinal Side Effects
Davidson et al.
Arch Intern Med 1999;159:1893-1900.
ABSTRACT
| FULL TEXT
Increased Cerebral CO2 Reactivity After Heparin-Mediated Extracorporal LDL Precipitation (HELP) in Patients With Coronary Heart Disease and Hyperlipidemia
Pfefferkorn et al.
Stroke 1999;30
:e1802-1806.
ABSTRACT
| FULL TEXT
Drug Treatment of Lipid Disorders
Knopp
NEJM 1999;341:498-511.
FULL TEXT
Cholesterol Lowering in the Elderly Population
Grundy et al.
Arch Intern Med 1999;159:1670-1678.
ABSTRACT
| FULL TEXT
Plasma lipid changes after supplementation with {beta}-glucan fiber from yeast
Nicolosi et al.
Am. J. Clin. Nutr. 1999;70:208-212.
ABSTRACT
| FULL TEXT
Intact Dietary Soy Protein, but Not Adding an Isoflavone-Rich Soy Extract to Casein, Improves Plasma Lipids in Ovariectomized Cynomolgus Monkeys
Greaves et al.
J. Nutr. 1999;129:1585-1592.
ABSTRACT
| FULL TEXT
Coronary Calcium Does Not Accurately Predict Near-Term Future Coronary Events in High-Risk Adults
Detrano et al.
Circulation 1999;99:2633-2638.
ABSTRACT
| FULL TEXT
Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density
Zambon et al.
Circulation 1999;99:1959-1964.
ABSTRACT
| FULL TEXT
Forecasting Patient Outcomes in the Management of Hyperlipidemia
Brier et al.
Arch Intern Med 1999;159:569-575.
ABSTRACT
| FULL TEXT
Cost-effectiveness of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors in the Secondary Prevention of Cardiovascular Disease: Forecasting the Incremental Benefits of Preventing Coronary and Cerebrovascular Events
Grover et al.
Arch Intern Med 1999;159:593-600.
ABSTRACT
| FULL TEXT
Continuous Combined Hormone Replacement Therapy Compared With Tibolone
AL-AZZAWI et al.
Obstet Gynecol 1999;93:258-264.
ABSTRACT
| FULL TEXT
National Trends in the Management of Cardiovascular Disease Risk Factors in Children: Second NHLBI Survey of Primary Care Physicians
Kimm et al.
Pediatrics 1998;102:50e-50.
ABSTRACT
| FULL TEXT
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Hulley et al.
JAMA 1998;280:605-613.
ABSTRACT
| FULL TEXT
Physical Activity Improves the Metabolic Risk Profiles in Men and Women: The Tromso Study
Thune et al.
Arch Intern Med 1998;158:1633-1640.
ABSTRACT
| FULL TEXT
Inhibition of Ileal Na+/Bile Acid Cotransporter by S-8921 Reduces Serum Cholesterol and Prevents Atherosclerosis in Rabbits
Higaki et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:1304-1311.
ABSTRACT
| FULL TEXT
Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
Circulation 1998;97:1440-1445.
ABSTRACT
| FULL TEXT
Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial
Sacks et al.
Circulation 1998;97:1446-1452.
ABSTRACT
| FULL TEXT
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
Pedersen et al.
Circulation 1998;97:1453-1460.
ABSTRACT
| FULL TEXT
Serum Cholesterol Distribution and Coronary Heart Disease Risk : Observations and Predictions Among Middle-aged Population in Eastern Finland
Jousilahti et al.
Circulation 1998;97:1087-1094.
ABSTRACT
| FULL TEXT
Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease: A Comparison of Primary vs Secondary Prevention
Grover et al.
Arch Intern Med 1998;158:655-662.
ABSTRACT
| FULL TEXT
Relationships of Abdominal Obesity and Hyperinsulinemia to Angiographically Assessed Coronary Artery Disease in Men With Known Mutations in the LDL Receptor Gene
Gaudet et al.
Circulation 1998;97:871-877.
ABSTRACT
| FULL TEXT
Treating Hyperlipidemia for the Primary Prevention of Coronary Disease: Are Higher Dosages of Lovastatin Cost-effective?
Perreault et al.
Arch Intern Med 1998;158:375-381.
ABSTRACT
| FULL TEXT
Overexpression of Cholesterol 7alpha -Hydroxylase (CYP7A) in Mice Lacking the Low Density Lipoprotein (LDL) Receptor Gene. LDL TRANSPORT AND PLASMA LDL CONCENTRATIONS ARE REDUCED
Spady et al.
J. Biol. Chem. 1998;273:126-132.
ABSTRACT
| FULL TEXT
Mechanism of Hypocholesterolemic Action of S-8921 in Rats: S-8921 Inhibits Ileal Bile Acid Absorption
Ichihashi et al.
J. Pharmacol. Exp. Ther. 1998;284:43-50.
ABSTRACT
| FULL TEXT
Cholesterol in Childhood
Committee on Nutrition
Pediatrics 1998;101:141-147.
ABSTRACT
| FULL TEXT
Cholesterol Management in Theory and Practice
Gotto
Circulation 1997;96:4424-4430.
ABSTRACT
| FULL TEXT
Heart Rate Adjustment of Exercise-Induced ST-Segment Depression Identifies Men Who Benefit From a Risk Factor Reduction Program
Okin et al.
Circulation 1997;96:2899-2904.
ABSTRACT
| FULL TEXT
Coronary Risk Estimation and Treatment of Hypercholesterolemia
Simon et al.
Circulation 1997;96:2449-2452.
ABSTRACT
| FULL TEXT
Lovastatin Decreases De Novo Cholesterol Synthesis and LDL Apo B-100 Production Rates in Combined-Hyperlipidemic Males
Cuchel et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1910-1917.
ABSTRACT
| FULL TEXT
Augmented Hepatic and Skeletal Thyromimetic Effects of Tiratricol in Comparison with Levothyroxine
Sherman et al.
J. Clin. Endocrinol. Metab. 1997;82:2153-2158.
ABSTRACT
| FULL TEXT
Effects of Contraceptive Estrogen and Progestin on the Atherogenic Potential of Plasma LDLs in Cynomolgus Monkeys
Manning et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1216-1223.
ABSTRACT
| FULL TEXT
